{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:37:38Z","timestamp":1788903458861,"version":"build-2803163510"},"reference-count":204,"publisher":"Georg Thieme Verlag KG","issue":"01","funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"crossref","award":["PID2021-123652OB-I00"],"award-info":[{"award-number":["PID2021-123652OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"crossref","award":["PID2021-124694OA-I00"],"award-info":[{"award-number":["PID2021-124694OA-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"crossref","award":["PID2022-141984OB-I00"],"award-info":[{"award-number":["PID2022-141984OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"crossref","award":["RYC2021-034121-I"],"award-info":[{"award-number":["RYC2021-034121-I"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"crossref","award":["RYC2022-036321-I"],"award-info":[{"award-number":["RYC2022-036321-I"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["RSG-22-061-01-MM"],"award-info":[{"award-number":["RSG-22-061-01-MM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["101077312"],"award-info":[{"award-number":["101077312"]}]},{"name":"NIH","award":["1R01DK133512"],"award-info":[{"award-number":["1R01DK133512"]}]},{"name":"NIH\/NCI","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"crossref","award":["77131383"],"award-info":[{"award-number":["77131383"]}],"id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Hepatic stellate cells (HSCs) are the liver's pericytes, and play key roles in liver homeostasis, regeneration, fibrosis, and cancer. Upon injury, HSCs activate and are the main origin of myofibroblasts and cancer-associated fibroblasts (CAFs) in liver fibrosis and cancer. Primary liver cancer has a grim prognosis, ranking as the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) being the predominant type, followed by intrahepatic cholangiocarcinoma (iCCA). Moreover, the liver hosts 35% of all metastatic lesions. The distinct spatial distribution and functional roles of HSCs across these malignancies represent a significant challenge for universal therapeutic strategies, requiring a nuanced and tailored understanding of their contributions. This review examines the heterogeneous roles of HSCs in liver cancer, focusing on their spatial localization, dynamic interactions within the tumor microenvironment (TME), and emerging therapeutic opportunities, including strategies to modulate their activity, and harness their potential as targets for antifibrotic and antitumor interventions.<\/jats:p>","DOI":"10.1055\/a-2551-0724","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:01:21Z","timestamp":1741219281000},"page":"033-051","source":"Crossref","is-referenced-by-count":12,"title":["Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer"],"prefix":"10.1055","volume":"45","author":[{"given":"Laura","family":"Sererols-Vi\u00f1as","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Garcia-Vici\u00e9n","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Ruiz-Bl\u00e1zquez","sequence":"additional","affiliation":[{"name":"University of Barcelona, Barcelona, Spain"},{"name":"Tissue Remodeling Fibrosis and Cancer Group, Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain"},{"name":"Institute of Biomedical Research of Barcelona (IDIBAPS), Barcelona, Spain"},{"name":"CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Fang","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmin A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Gonzalez-Sanchez","sequence":"additional","affiliation":[{"name":"HepatoBiliary Tumours Lab, Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC-Universidad de Salamanca, Salamanca, Spain"},{"name":"Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vaquero","sequence":"additional","affiliation":[{"name":"CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"HepatoBiliary Tumours Lab, Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC-Universidad de Salamanca, Salamanca, Spain"},{"name":"TGF-\u03b2 and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moles","sequence":"additional","affiliation":[{"name":"Tissue Remodeling Fibrosis and Cancer Group, Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain"},{"name":"Institute of Biomedical Research of Barcelona (IDIBAPS), Barcelona, Spain"},{"name":"CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aveline","family":"Filliol","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Aff\u00f2","sequence":"additional","affiliation":[{"name":"Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"J M Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","article-title":"Colorectal liver metastases: current management and future perspectives","volume":"11","author":"J Martin","year":"2020","journal-title":"World J Clin Oncol"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/s41591-024-03075-7","article-title":"Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer","volume":"30","author":"L Bojmar","year":"2024","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"S Affo","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/S2468-2667(24)00002-1","article-title":"Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities","volume":"9","author":"G UHD Collaborators","year":"2024","journal-title":"Lancet Public Health"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Z Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"D Q Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"D R Kamm","year":"2022","journal-title":"J Physiol"},{"issue":"08","key":"ref10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"S L Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"V Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jcmgh.2023.01.006","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma","volume":"15","author":"F Ying","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7931","key":"ref13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"A Filliol","year":"2022","journal-title":"Nature"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"B Cogliati","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000198640","article-title":"The lipocytes in normal human liver. A quantitative study","volume":"22","author":"M P Giampieri","year":"1981","journal-title":"Digestion"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.22721","article-title":"Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development","volume":"49","author":"K Asahina","year":"2009","journal-title":"Hepatology"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"e24993","DOI":"10.1371\/journal.pone.0024993","article-title":"Distinct populations of hepatic stellate cells in the mouse liver have different capacities for retinoid and lipid storage","volume":"6","author":"D N D'Ambrosio","year":"2011","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"I Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"ref19","first-page":"2589","article-title":"Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies","volume":"101223","author":"V Merens","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.24119","article-title":"Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver","volume":"53","author":"K Asahina","year":"2011","journal-title":"Hepatology"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","article-title":"Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis","volume":"29","author":"R Dobie","year":"2019","journal-title":"Cell Rep"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.jhepr.2021.100278","article-title":"Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity","volume":"3","author":"V L Payen","year":"2021","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","article-title":"Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage","volume":"1791","author":"W S Blaner","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"S L Friedman","year":"2008","journal-title":"Physiol Rev"},{"issue":"677","key":"ref25","doi-asserted-by":"crossref","first-page":"eadd3949","DOI":"10.1126\/scitranslmed.add3949","article-title":"An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis","volume":"15","author":"S Wang","year":"2023","journal-title":"Sci Transl Med"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.22351","article-title":"Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence","volume":"48","author":"L D Deleve","year":"2008","journal-title":"Hepatology"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2013.09.013","article-title":"A novel mouse model of depletion of stellate cells clarifies their role in ischemia\/reperfusion- and endotoxin-induced acute liver injury","volume":"60","author":"R K Stewart","year":"2014","journal-title":"J Hepatol"},{"issue":"787","key":"ref28","doi-asserted-by":"crossref","first-page":"eadf6696","DOI":"10.1126\/scisignal.adf6696","article-title":"Hepatic stellate cells maintain liver homeostasis through paracrine neurotrophin-3 signaling that induces hepatocyte proliferation","volume":"16","author":"V Q Trinh","year":"2023","journal-title":"Sci Signal"},{"issue":"07","key":"ref29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"T Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbadis.2013.02.019","article-title":"Origins and functions of liver myofibroblasts","volume":"1832","author":"S Lemoinne","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"S 03","key":"ref31","first-page":"S84","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"T Kisseleva","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"32","key":"ref32","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"K Iwaisako","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"18840","DOI":"10.1038\/s41598-024-69898-z","article-title":"Hepatic stellate cells in zone 1 engage in capillarization rather than myofibroblast formation in murine liver fibrosis","volume":"14","author":"M A Khan","year":"2024","journal-title":"Sci Rep"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/1535370215584933","article-title":"Bone marrow-derived fibrocytes contribute to liver fibrosis","volume":"240","author":"J Xu","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/hep.31987","article-title":"Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice","volume":"74","author":"W Yang","year":"2021","journal-title":"Hepatology"},{"issue":"7783","key":"ref36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"P Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcmgh.2024.01.002","article-title":"\u201cThe good, the bad, and the ugly\u201d\u2014about diverse phenotypes of hepatic stellate cells in the liver","volume":"17","author":"A Bogomolova","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"J S Troeger","year":"2012","journal-title":"Gastroenterology"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","article-title":"Mechanisms of liver fibrosis resolution","volume":"63","author":"F Tacke","year":"2015","journal-title":"J Hepatol"},{"issue":"24","key":"ref40","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"T Kisseleva","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"J P Iredale","year":"1998","journal-title":"J Clin Invest"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"V Krizhanovsky","year":"2008","journal-title":"Cell"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41467-018-03555-8","article-title":"Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells","volume":"9","author":"A Takahashi","year":"2018","journal-title":"Nat Commun"},{"issue":"22","key":"ref44","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s00018-014-1691-3","article-title":"Physiological and pathological consequences of cellular senescence","volume":"71","author":"D G Burton","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2024.03.014","article-title":"Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis","volume":"81","author":"C N Yashaswini","year":"2024","journal-title":"J Hepatol"},{"issue":"7456","key":"ref46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"S Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2013.03.020","article-title":"Non-cell-autonomous tumor suppression by p53","volume":"153","author":"A Lujambio","year":"2013","journal-title":"Cell"},{"issue":"7814","key":"ref48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"C Amor","year":"2020","journal-title":"Nature"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41556-020-0511-2","article-title":"FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome","volume":"22","author":"F Li","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"J M Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"08","key":"ref51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41419-023-06077-4","article-title":"Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice","volume":"14","author":"J Otto","year":"2023","journal-title":"Cell Death Dis"},{"issue":"S 01","key":"ref52","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/modpathol.3800682","article-title":"Neoplasms of the liver","volume":"20","author":"Z D Goodman","year":"2007","journal-title":"Mod Pathol"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.27822","article-title":"Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma","volume":"62","author":"J Ji","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3181f31caa","article-title":"Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD\/NASH","volume":"34","author":"M Salomao","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"06","key":"ref55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","article-title":"Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met\/FRA1\/HEY1 signaling","volume":"15","author":"E Y Lau","year":"2016","journal-title":"Cell Rep"},{"issue":"04","key":"ref56","first-page":"4805","article-title":"The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and \u03b1-SMA","volume":"15","author":"M Fang","year":"2018","journal-title":"Oncol Lett"},{"issue":"09","key":"ref57","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.xcrm.2023.101170","article-title":"The extracellular matrix in hepatocellular carcinoma: mechanisms and therapeutic vulnerability","volume":"4","author":"A M Roy","year":"2023","journal-title":"Cell Rep Med"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/a-2404-7973","article-title":"Hepatic extracellular matrix and its role in the regulation of liver phenotype","volume":"44","author":"G E Arteel","year":"2024","journal-title":"Semin Liver Dis"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","article-title":"Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography","volume":"49","author":"R Masuzaki","year":"2009","journal-title":"Hepatology"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2013.11.016","article-title":"Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest\u2122) and transient elastography (FibroScan\u00ae)","volume":"60","author":"T Poynard","year":"2014","journal-title":"J Hepatol"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/liv.12118","article-title":"Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients","volume":"33","author":"H M Wang","year":"2013","journal-title":"Liver Int"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"goae085","DOI":"10.1093\/gastro\/goae085","article-title":"New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradication","volume":"12","author":"C Q Pan","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"07","key":"ref63","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2013.5697","article-title":"Extracellular matrix and liver disease","volume":"21","author":"E Arriazu","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"J C Nault","year":"2014","journal-title":"Hepatology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"J C Nault","year":"2013","journal-title":"Nat Commun"},{"issue":"07","key":"ref66","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2023.02.043","article-title":"A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23","volume":"164","author":"Y Saito","year":"2023","journal-title":"Gastroenterology"},{"issue":"02","key":"ref67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0039-3402516","article-title":"The matrisome, inflammation, and liver disease","volume":"40","author":"C E Dolin","year":"2020","journal-title":"Semin Liver Dis"},{"issue":"03","key":"ref68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.1.3.297","article-title":"Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts","volume":"1","author":"M G Stoker","year":"1966","journal-title":"J Cell Sci"},{"issue":"48","key":"ref69","doi-asserted-by":"crossref","first-page":"17188","DOI":"10.1073\/pnas.1419554111","article-title":"Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent","volume":"111","author":"T Alkasalias","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"07","key":"ref70","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/cam4.707","article-title":"Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development","volume":"5","author":"L Zhou","year":"2016","journal-title":"Cancer Med"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.24162","article-title":"Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice","volume":"53","author":"H S Chou","year":"2011","journal-title":"Hepatology"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2013.04.011","article-title":"Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C","volume":"59","author":"B Langhans","year":"2013","journal-title":"J Hepatol"},{"issue":"05","key":"ref73","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","article-title":"Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid","volume":"190","author":"R M Dunham","year":"2013","journal-title":"J Immunol"},{"issue":"02","key":"ref74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/ijo.2012.1497","article-title":"The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma","volume":"41","author":"W Zhao","year":"2012","journal-title":"Int J Oncol"},{"issue":"08","key":"ref75","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.4049\/jimmunol.1102460","article-title":"Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance","volume":"188","author":"A Dangi","year":"2012","journal-title":"J Immunol"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TP.0b013e318294caae","article-title":"Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway","volume":"96","author":"R Charles","year":"2013","journal-title":"Transplantation"},{"issue":"06","key":"ref77","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.20488","article-title":"Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice","volume":"40","author":"M C Yu","year":"2004","journal-title":"Hepatology"},{"issue":"07","key":"ref78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10585-011-9399-3","article-title":"Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma","volume":"28","author":"Y Xia","year":"2011","journal-title":"Clin Exp Metastasis"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3892\/or.2013.2571","article-title":"T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma","volume":"30","author":"Y H Xia","year":"2013","journal-title":"Oncol Rep"},{"issue":"11","key":"ref80","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/ijc.25920","article-title":"Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice","volume":"129","author":"W Zhao","year":"2011","journal-title":"Int J Cancer"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO","volume":"318","author":"T Li","year":"2012","journal-title":"Cancer Lett"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"44544","DOI":"10.1038\/srep44544","article-title":"Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-\u03b2-dependent emperipolesis in HBV cirrhotic patients","volume":"7","author":"J Shi","year":"2017","journal-title":"Sci Rep"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2008.00610.x","article-title":"Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape","volume":"222","author":"J B Katz","year":"2008","journal-title":"Immunol Rev"},{"issue":"07","key":"ref84","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-013-1434-6","article-title":"Immune-suppressive properties of the tumor microenvironment","volume":"62","author":"J C Becker","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"627927","DOI":"10.3389\/fmed.2021.627927","article-title":"Activated hepatic stellate cells induce infiltration and formation of CD163+ macrophages via CCL2\/CCR2 pathway","volume":"8","author":"S Xi","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"J P Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"T M Savage","year":"2024","journal-title":"Immunity"},{"issue":"04","key":"ref88","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","article-title":"Role of epithelial to mesenchymal transition in hepatocellular carcinoma","volume":"65","author":"G Giannelli","year":"2016","journal-title":"J Hepatol"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-017-02696-6","article-title":"Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGF\u03b2 enhance the efficacy of cancer immunotherapy","volume":"9","author":"R Ravi","year":"2018","journal-title":"Nat Commun"},{"issue":"05","key":"ref90","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"L D DeLeve","year":"2015","journal-title":"Hepatology"},{"issue":"04","key":"ref91","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","article-title":"Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats","volume":"142","author":"G Xie","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"ref92","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nmat5024","article-title":"Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis","volume":"16","author":"L Liu","year":"2017","journal-title":"Nat Mater"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12072-010-9192-4","article-title":"Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration","volume":"4","author":"J A Chen","year":"2010","journal-title":"Hepatol Int"},{"issue":"03","key":"ref94","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/hepr.12356","article-title":"Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma","volume":"45","author":"N Lin","year":"2015","journal-title":"Hepatol Res"},{"issue":"03","key":"ref95","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hep.30294","article-title":"Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease","volume":"69","author":"S Lefere","year":"2019","journal-title":"Hepatology"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(24)02575-3","article-title":"Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study","volume":"405","author":"M Kudo","year":"2025","journal-title":"Lancet"},{"issue":"20","key":"ref97","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"R S Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"08","key":"ref99","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2468-1253(23)00111-5","article-title":"Fibroblasts in liver cancer: functions and therapeutic translation","volume":"8","author":"S Affo","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"ref100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"J M Llovet","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biocel.2016.08.017","article-title":"\u201cFibrous nests\u201d in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome","volume":"81","author":"R D\u00e9sert","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"issue":"03","key":"ref102","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/HEP.0000000000000362","article-title":"Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT\/TGFB signatures, associated with poor outcome","volume":"78","author":"R Desert","year":"2023","journal-title":"Hepatology"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s43018-023-00672-2","article-title":"Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy","volume":"5","author":"Z Li","year":"2024","journal-title":"Nat Cancer"},{"issue":"7938","key":"ref104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"R Xue","year":"2022","journal-title":"Nature"},{"issue":"08","key":"ref105","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","article-title":"Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma","volume":"28","author":"A X Zhu","year":"2022","journal-title":"Nat Med"},{"issue":"10","key":"ref106","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s43018-024-00824-y","article-title":"Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma","volume":"5","author":"X Qiu","year":"2024","journal-title":"Nat Cancer"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Y Liu","year":"2023","journal-title":"J Hepatol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"1135456","DOI":"10.3389\/fonc.2023.1135456","article-title":"Cancer immune exclusion: breaking the barricade for a successful immunotherapy","volume":"13","author":"S Bruni","year":"2023","journal-title":"Front Oncol"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-023-01218-y","article-title":"Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence","volume":"15","author":"S Zhang","year":"2023","journal-title":"Genome Med"},{"issue":"06","key":"ref110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"A Bagaev","year":"2021","journal-title":"Cancer Cell"},{"issue":"01","key":"ref111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.32573","article-title":"Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma","volume":"77","author":"H Murai","year":"2023","journal-title":"Hepatology"},{"issue":"7886","key":"ref112","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"X Sun","year":"2021","journal-title":"Nature"},{"issue":"09","key":"ref113","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ajpath.2021.05.019","article-title":"Nondegradable collagen increases liver fibrosis but not hepatocellular carcinoma in mice","volume":"191","author":"J Baglieri","year":"2021","journal-title":"Am J Pathol"},{"issue":"07","key":"ref114","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41418-023-01166-5","article-title":"Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression","volume":"30","author":"Y X Xiong","year":"2023","journal-title":"Cell Death Differ"},{"issue":"7931","key":"ref115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","article-title":"Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome","volume":"610","author":"H Su","year":"2022","journal-title":"Nature"},{"issue":"03","key":"ref116","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0039-1685539","article-title":"Contributions of fibroblasts, extracellular matrix, stiffness, and mechanosensing to hepatocarcinogenesis","volume":"39","author":"A Filliol","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"06","key":"ref117","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"S Affo","year":"2021","journal-title":"Cancer Cell"},{"issue":"11","key":"ref118","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"S Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"issue":"03","key":"ref119","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/15384047.2019.1685157","article-title":"CXCR4\/TGF-\u03b21 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer","volume":"21","author":"H X Tan","year":"2020","journal-title":"Cancer Biol Ther"},{"issue":"09","key":"ref120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4254\/wjh.v9.i9.455","article-title":"Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness","volume":"9","author":"S Brivio","year":"2017","journal-title":"World J Hepatol"},{"issue":"02","key":"ref121","doi-asserted-by":"crossref","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: a strained relationship","volume":"1873","author":"B Piersma","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"06","key":"ref122","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41416-022-01859-7","article-title":"Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights","volume":"127","author":"E Latacz","year":"2022","journal-title":"Br J Cancer"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.acr.2022.01.009","article-title":"Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance","volume":"156","author":"A Ravichandra","year":"2022","journal-title":"Adv Cancer Res"},{"issue":"04","key":"ref124","first-page":"941","article-title":"Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma","volume":"79","author":"P Cantallops Vil\u00e0","year":"2024","journal-title":"Hepatology"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","article-title":"Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma","volume":"73","author":"J C Mertens","year":"2013","journal-title":"Cancer Res"},{"issue":"02","key":"ref126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41416-021-01569-6","article-title":"Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma","volume":"126","author":"C Lan","year":"2022","journal-title":"Br J Cancer"},{"issue":"06","key":"ref127","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"B C \u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"issue":"02","key":"ref128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"I D Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"07","key":"ref129","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"M Akita","year":"2017","journal-title":"Mod Pathol"},{"issue":"06","key":"ref130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hpb.2019.10.009","article-title":"Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypes","volume":"22","author":"T Chung","year":"2020","journal-title":"HPB (Oxford)"},{"issue":"01","key":"ref131","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1038\/s41467-023-40688-x","article-title":"An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver","volume":"14","author":"C Fern\u00e1ndez Moro","year":"2023","journal-title":"Nat Commun"},{"issue":"03","key":"ref132","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00795-024-00392-1","article-title":"Histopathological growth pattern and vessel co-option in intrahepatic cholangiocarcinoma","volume":"57","author":"Z Li","year":"2024","journal-title":"Med Mol Morphol"},{"issue":"04","key":"ref133","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijms22041544","article-title":"The tumor microenvironment in liver metastases from colorectal carcinoma in the context of the histologic growth patterns","volume":"22","author":"G Garcia-Vici\u00e9n","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref134","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/cancers14030689","article-title":"Spatial immunology in liver metastases from colorectal carcinoma according to the histologic growth pattern","volume":"14","author":"G Garcia-Vici\u00e9n","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"ref135","doi-asserted-by":"crossref","first-page":"e70000","DOI":"10.1002\/mco2.70000","article-title":"The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells","volume":"5","author":"G Garcia-Vici\u00e9n","year":"2024","journal-title":"MedComm"},{"issue":"03","key":"ref136","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ajpath.2024.07.009","article-title":"Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma: insights into origins, heterogeneity, lymphangiogenesis, and peritoneal metastasis","volume":"195","author":"S Aff\u00f2","year":"2025","journal-title":"Am J Pathol"},{"issue":"05","key":"ref137","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"M Zhang","year":"2020","journal-title":"J Hepatol"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"M A Martin-Serrano","year":"2023","journal-title":"Gut"},{"issue":"04","key":"ref139","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Y Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"e180802","DOI":"10.1172\/JCI180802","article-title":"Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment","author":"Y M Yang","year":"2025","journal-title":"J Clin Invest"},{"issue":"11","key":"ref141","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology","volume":"18","author":"M D Giraldez","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"02","key":"ref142","first-page":"302","article-title":"Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6\/STAT3\/Notch signaling","volume":"8","author":"S Xiong","year":"2018","journal-title":"Am J Cancer Res"},{"issue":"01","key":"ref143","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12967-023-03977-z","article-title":"Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6\/STAT3","volume":"21","author":"X Li","year":"2023","journal-title":"J Transl Med"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"B Huang","year":"2022","journal-title":"Front Oncol"},{"issue":"04","key":"ref145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"D E Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"103902","DOI":"10.1016\/j.critrevonc.2022.103902","article-title":"Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver","volume":"182","author":"D Ezhilarasan","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"21","key":"ref147","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jcm11216498","article-title":"Cancer-associated fibroblasts in cholangiocarcinoma: current knowledge and possible implications for therapy","volume":"11","author":"M Montori","year":"2022","journal-title":"J Clin Med"},{"issue":"03","key":"ref148","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0040-1705109","article-title":"Liver matrix in benign and malignant biliary tract disease","volume":"40","author":"L Fabris","year":"2020","journal-title":"Semin Liver Dis"},{"issue":"06","key":"ref149","first-page":"8681","article-title":"Tumor-associated macrophages recruited by periostin in intrahepatic cholangiocarcinoma stem cells","volume":"15","author":"J Zeng","year":"2018","journal-title":"Oncol Lett"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19336918.2015.1008331","article-title":"Tenascin C in metastasis: a view from the invasive front","volume":"9","author":"C M Lowy","year":"2015","journal-title":"Cell Adh Migr"},{"issue":"05","key":"ref151","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"K R Levental","year":"2009","journal-title":"Cell"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ceb.2018.09.002","article-title":"Cancer associated fibroblasts: is the force the path to the dark side?","volume":"56","author":"J Barbaz\u00e1n","year":"2019","journal-title":"Curr Opin Cell Biol"},{"issue":"06","key":"ref153","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"T F Greten","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"03","key":"ref154","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"J J Havel","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"03","key":"ref155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.trecan.2018.01.007","article-title":"Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma","volume":"4","author":"D H\u00f8gdall","year":"2018","journal-title":"Trends Cancer"},{"issue":"08","key":"ref156","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1349-7006.2010.01614.x","article-title":"Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma","volume":"101","author":"H Hasita","year":"2010","journal-title":"Cancer Sci"},{"issue":"04","key":"ref157","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","article-title":"Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"127","author":"D Konishi","year":"2022","journal-title":"Br J Cancer"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"104295","DOI":"10.1016\/j.cellimm.2021.104295","article-title":"MDSCs in liver cancer: a critical tumor-promoting player and a potential therapeutic target","volume":"361","author":"C Ma","year":"2021","journal-title":"Cell Immunol"},{"issue":"05","key":"ref159","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.32222","article-title":"Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma","volume":"75","author":"C L Zimmer","year":"2022","journal-title":"Hepatology"},{"issue":"02","key":"ref160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/bjc.2017.401","article-title":"Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma","volume":"118","author":"Y Kitano","year":"2018","journal-title":"Br J Cancer"},{"issue":"10","key":"ref161","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","article-title":"Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation","volume":"42","author":"Y Gao","year":"2024","journal-title":"Cancer Cell"},{"issue":"10","key":"ref162","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"E Loeuillard","year":"2020","journal-title":"J Clin Invest"},{"issue":"04","key":"ref163","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"M Cadamuro","year":"2019","journal-title":"J Hepatol"},{"issue":"07","key":"ref164","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"T A Wynn","year":"2012","journal-title":"Nat Med"},{"issue":"02","key":"ref165","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"F Tacke","year":"2023","journal-title":"J Hepatol"},{"issue":"7835","key":"ref166","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"N C Henderson","year":"2020","journal-title":"Nature"},{"issue":"08","key":"ref167","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/1744666X.2024.2380894","article-title":"CAR-T cell technologies that interact with the tumour microenvironment in solid tumours","volume":"20","author":"C A Taylor","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"issue":"26","key":"ref168","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood.2021012811","article-title":"Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma","volume":"139","author":"R Sakemura","year":"2022","journal-title":"Blood"},{"issue":"01","key":"ref169","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12967-023-04080-z","article-title":"FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer","volume":"21","author":"Y Liu","year":"2023","journal-title":"J Transl Med"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"1172681","DOI":"10.3389\/fimmu.2023.1172681","article-title":"Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy","volume":"14","author":"S Das","year":"2023","journal-title":"Front Immunol"},{"issue":"14","key":"ref171","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","article-title":"Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells","volume":"75","author":"A Lo","year":"2015","journal-title":"Cancer Res"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1479-5876-11-187","article-title":"Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells","volume":"11","author":"P C Schuberth","year":"2013","journal-title":"J Transl Med"},{"issue":"12","key":"ref173","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"W H Wilson","year":"2010","journal-title":"Lancet Oncol"},{"issue":"01","key":"ref174","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.annonc.2020.10.474","article-title":"Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial","volume":"32","author":"S Hiltbrunner","year":"2021","journal-title":"Ann Oncol"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/1471-2407-12-615","article-title":"Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)","volume":"12","author":"U Petrausch","year":"2012","journal-title":"BMC Cancer"},{"issue":"695","key":"ref176","doi-asserted-by":"crossref","first-page":"eabp9229","DOI":"10.1126\/scitranslmed.abp9229","article-title":"A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors","volume":"15","author":"I Melero","year":"2023","journal-title":"Sci Transl Med"},{"issue":"05","key":"ref177","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cancers15051357","article-title":"Challenges of anti-mesothelin CAR-T-cell therapy","volume":"15","author":"X Zhai","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"06","key":"ref178","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"H Huang","year":"2022","journal-title":"Cancer Cell"},{"issue":"31","key":"ref179","doi-asserted-by":"crossref","first-page":"e2403002121","DOI":"10.1073\/pnas.2403002121","article-title":"Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer","volume":"121","author":"U Amit","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref180","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1158\/0008-5472.CAN-20-2701","article-title":"Mesothelin-specific CAR T cells target ovarian cancer","volume":"81","author":"E Schoutrop","year":"2021","journal-title":"Cancer Res"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"958082","DOI":"10.3389\/fimmu.2022.958082","article-title":"Development of Nectin4\/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors","volume":"13","author":"F Li","year":"2022","journal-title":"Front Immunol"},{"issue":"09","key":"ref182","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-23-3841","article-title":"Mesothelin CAR T cells secreting anti-FAP\/anti-CD3 molecules efficiently target pancreatic adenocarcinoma and its stroma","volume":"30","author":"M Wehrli","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"02","key":"ref183","first-page":"12","article-title":"Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis","volume":"12","author":"S L Ash","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"01","key":"ref184","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-024-01525-w","article-title":"IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts","volume":"17","author":"A Van den Eynde","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"07","key":"ref185","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","article-title":"CD70-targeted allogeneic CAR T-cell therapy for advanced clear cell renal cell carcinoma","volume":"14","author":"S K Pal","year":"2024","journal-title":"Cancer Discov"},{"issue":"07","key":"ref186","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"J I Belle","year":"2024","journal-title":"Cancer Discov"},{"issue":"07","key":"ref187","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate immunosuppression and drive breast cancer progression","volume":"14","author":"J Ye","year":"2024","journal-title":"Cancer Discov"},{"issue":"05","key":"ref188","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/acsnano.0c00417","article-title":"Photothermal depletion of cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma","volume":"14","author":"A Nicol\u00e1s-Boluda","year":"2020","journal-title":"ACS Nano"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7554\/eLife.58688","article-title":"Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment","volume":"10","author":"A Nicolas-Boluda","year":"2021","journal-title":"eLife"},{"issue":"05","key":"ref190","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2023.11.302","article-title":"Fibroblast-derived lysyl oxidase increases oxidative phosphorylation and stemness in cholangiocarcinoma","volume":"166","author":"M Lewinska","year":"2024","journal-title":"Gastroenterology"},{"issue":"04","key":"ref191","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","author":"S A Harrison","year":"2018","journal-title":"Gastroenterology"},{"issue":"04","key":"ref192","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.jhepr.2020.100115","article-title":"The liver matrisome\u2014looking beyond collagens","volume":"2","author":"G E Arteel","year":"2020","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"11","key":"ref193","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/cncr.30571","article-title":"A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma","volume":"123","author":"L Goyal","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"ref194","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s11095-007-9316-2","article-title":"Pharmacokinetics and safety of a fully human hepatocyte growth factor antibody, AMG 102, in cynomolgus monkeys","volume":"24","author":"T Kakkar","year":"2007","journal-title":"Pharm Res"},{"issue":"02","key":"ref195","doi-asserted-by":"crossref","first-page":"G234","DOI":"10.1152\/ajpgi.00254.2021","article-title":"Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis","volume":"322","author":"E Kostallari","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"05","key":"ref196","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cells8050503","article-title":"Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis","volume":"8","author":"O Krenkel","year":"2019","journal-title":"Cells"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001021","article-title":"CX 3 CR1 + macrophages interact with HSCs to promote HCC through CD8 + T-cell suppression","author":"J M Jeong","year":"2024","journal-title":"Hepatology"},{"issue":"03","key":"ref198","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","article-title":"Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion","volume":"59","author":"B H\u00f6chst","year":"2013","journal-title":"J Hepatol"},{"issue":"08","key":"ref199","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.18632\/oncotarget.6839","article-title":"Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2","volume":"7","author":"Y Xu","year":"2016","journal-title":"Oncotarget"},{"issue":"03","key":"ref200","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"E Seki","year":"2015","journal-title":"Hepatology"},{"issue":"08","key":"ref201","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"R A Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"04","key":"ref202","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Y Cheng","year":"2018","journal-title":"Cell Death Dis"},{"issue":"03","key":"ref203","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/HEP.0000000000000965","article-title":"Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: a randomized phase 2\/3 trial","volume":"81","author":"D Y Oh","year":"2025","journal-title":"Hepatology"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"760971","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","volume":"11","author":"J Xu","year":"2021","journal-title":"Front Oncol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2551-0724.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T23:00:58Z","timestamp":1745622058000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2551-0724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":204,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2025,4,25]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2551-0724","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,5]]},"published":{"date-parts":[[2025,3]]}}}